메뉴 건너뛰기




Volumn 15, Issue 2, 2011, Pages 151-155

Dyslipidemia in AIDS patients on highly active antiretroviral therapy

Author keywords

AIDS; Dyslipidemia; HAART; HIV; Prevalence

Indexed keywords

ANTILIPEMIC AGENT; ATAZANAVIR; EFAVIRENZ; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMIVUDINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; ZIDOVUDINE;

EID: 79959625616     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1590/S1413-86702011000200010     Document Type: Article
Times cited : (17)

References (20)
  • 1
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
    • Palella FJ, Jr., Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26; 338(13):853-60.
    • (1998) N Engl J Med , vol.338 , Issue.13 , pp. 853-860
    • Palella Jr., F.J.1    Delaney, K.M.2    Moorman, A.C.3
  • 2
    • 3042654825 scopus 로고    scopus 로고
    • Treatment outcomes afer highly active antiretroviral therapy: A meta-analysis of randomised controlled trials
    • Enanoria WT, Ng C, Saha SR, Colford Jr JM. Treatment outcomes afer highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2004; 4(7):414-25.
    • (2004) Lancet Infect Dis , vol.4 , Issue.7 , pp. 414-425
    • Enanoria, W.T.1    Ng, C.2    Saha, S.R.3    Colford Jr., J.M.4
  • 3
    • 0034699898 scopus 로고    scopus 로고
    • Adverse efects of antiretroviral therapy
    • Carr A, Cooper DA. Adverse efects of antiretroviral therapy. Lancet. 2000; 356(9239):1423-30.
    • (2000) Lancet , vol.356 , Issue.9239 , pp. 1423-1430
    • Carr, A.1    Cooper, D.A.2
  • 4
    • 33747605338 scopus 로고    scopus 로고
    • Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
    • Wohl DA, McComsey G, Tebas P et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis. 2006; 43(5):645-53.
    • (2006) Clin Infect Dis , vol.43 , Issue.5 , pp. 645-653
    • Wohl, D.A.1    Mccomsey, G.2    Tebas, P.3
  • 5
    • 0142043954 scopus 로고    scopus 로고
    • Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: A systematic review
    • Rhew DC, Bernal M, Aguilar D, Iloeje U, Goetz MB. Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review. Clin Infect Dis. 2003; 37(7):959-72.
    • (2003) Clin Infect Dis , vol.37 , Issue.7 , pp. 959-972
    • Rhew, D.C.1    Bernal, M.2    Aguilar, D.3    Iloeje, U.4    Goetz, M.B.5
  • 6
    • 0042768569 scopus 로고    scopus 로고
    • Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population
    • Saves M, Chene G, Ducimetiere P et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis., 2003; 37(2):292-8.
    • (2003) Clin Infect Dis , vol.37 , Issue.2 , pp. 292-298
    • Saves, M.1    Chene, G.2    Ducimetiere, P.3
  • 7
    • 34247537169 scopus 로고    scopus 로고
    • Class of antiretroviral drugs and the risk of myocardial infarction
    • Friis-Moller N, Reiss P, Sabin CA et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35.
    • (2007) N Engl J Med , vol.356 , Issue.17 , pp. 1723-1735
    • Friis-Moller, N.1    Reiss, P.2    Sabin, C.A.3
  • 8
    • 33744475605 scopus 로고    scopus 로고
    • Sustainability of Brazilian policy for access to antiretroviral drugs
    • Grangeiro A Teixeira L, Bastos FI, Teixeira P. Sustainability of Brazilian policy for access to antiretroviral drugs. Rev Saude Publica. 2006; 40 Suppl:60-9.
    • (2006) Rev Saude Publica , vol.40 , Issue.SUPPL , pp. 60-69
    • Grangeiro, A.1    Teixeira, L.2    Bastos, F.I.3    Teixeira, P.4
  • 9
    • 33744469563 scopus 로고    scopus 로고
    • AIDS epidemic trends afer the introduction of antiretroviral therapy in Brazil
    • Dourado I, Veras MA, Barreira D, de Brito AM. AIDS epidemic trends afer the introduction of antiretroviral therapy in Brazil. Rev Saude Publica. 2006; 40 Suppl:9-17.
    • (2006) Rev Saude Publica , vol.40 , Issue.SUPPL. , pp. 9-17
    • Dourado, I.1    Veras, M.A.2    Barreira, D.3    de Brito, A.M.4
  • 10
    • 0035749781 scopus 로고    scopus 로고
    • Hyperlipidemia related to the use of HIV-protease inhibitors: Natural history and results of treatment with fenofbrate
    • Caramelli B, de Bernoche CY, Sartori AM et al. Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofbrate. Braz J Infect Dis. 2001; 5(6):332-8.
    • (2001) Braz J Infect Dis , vol.5 , Issue.6 , pp. 332-338
    • Caramelli, B.1    de Bernoche, C.Y.2    Sartori, A.M.3
  • 11
    • 27344444022 scopus 로고    scopus 로고
    • High frequency of Fredricksons phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus
    • Albuquerque EM, de Faria EC, Oliveira HC, Magro DO, Castilho LN. High frequency of Fredricksons phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus. BMC Infect Dis. 2005; 5(1):47.
    • (2005) BMC Infect Dis , vol.5 , Issue.1 , pp. 47
    • Albuquerque, E.M.1    de Faria, E.C.2    Oliveira, H.C.3    Magro, D.O.4    Castilho, L.N.5
  • 13
    • 0035524623 scopus 로고    scopus 로고
    • SBC. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia
    • SBC. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2001;77 Suppl 3:1-48.
    • (2001) Arq Bras Cardiol , vol.77 , Issue.SUPPL. 3 , pp. 1-48
  • 14
    • 0020663195 scopus 로고
    • Summary estimates of cholesterol used to predict coronary heart disease
    • Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983; 67(4):730-4.
    • (1983) Circulation , vol.67 , Issue.4 , pp. 730-734
    • Castelli, W.P.1    Abbott, R.D.2    Mcnamara, P.M.3
  • 15
    • 0042832397 scopus 로고    scopus 로고
    • Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
    • Dube M P, Stein JH, Aberg JA et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003; 37(5):613-27.
    • (2003) Clin Infect Dis , vol.37 , Issue.5 , pp. 613-627
    • Dube, M.P.1    Stein, J.H.2    Aberg, J.A.3
  • 17
    • 12144286934 scopus 로고    scopus 로고
    • Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
    • Fontas E, van Leth F, Sabin CA et al. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis. 2004; 189(6):1056-74.
    • (2004) J Infect Dis , vol.189 , Issue.6 , pp. 1056-1074
    • Fontas, E.1    van Leth, F.2    Sabin, C.A.3
  • 18
    • 0038386036 scopus 로고    scopus 로고
    • Cardiovascular disease risk factors in HIV patient - association with antiretroviral therapy. Results from the DAD study
    • Friis-Moller N, Weber R, Reiss P et al. Cardiovascular disease risk factors in HIV patient - association with antiretroviral therapy. Results from the DAD study. Aids. 2003; 17(8):1179-93.
    • (2003) Aids , vol.17 , Issue.8 , pp. 1179-1193
    • Friis-Moller, N.1    Weber, R.2    Reiss, P.3
  • 19
    • 0034253091 scopus 로고    scopus 로고
    • Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy
    • Matthews GV, Moyle GJ, Mandalia S, Bower M, Nelson M, Gazzard BG. Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy. J Acquir Immune Defc Syndr. 2000; 24(4):310-5.
    • (2000) J Acquir Immune Defc Syndr , vol.24 , Issue.4 , pp. 310-315
    • Matthews, G.V.1    Moyle, G.J.2    Mandalia, S.3    Bower, M.4    Nelson, M.5    Gazzard, B.G.6
  • 20
    • 0035824764 scopus 로고    scopus 로고
    • Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
    • van der Valk M, Kastelein JJ, Murphy RL et al. Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. Aids. 2001; 15(18):2407-14.
    • (2001) Aids , vol.15 , Issue.18 , pp. 2407-2414
    • van der Valk, M.1    Kastelein, J.J.2    Murphy, R.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.